Meredith Salisbury, is the editor of Genome Technology, the one 'trade' publication everyone must read to learn about the tools and toolmakers that will shape medicine in the 21st century. In the current issue of her publication she has put together the Myths and Misconceptions the people hold about patenting ideas in academia. Most of them comprise the intellectual framework of those that want to drive companies and private investment out of medicine altogether. They are Luddites. As Ms. Salisbury points out concisely and elegantly:
"...More academics follow through on patenting because it can be the fastest and most effective way of getting a research breakthrough to the public. Companies that have to commercialize new technology or other types of discovers want some assurance that they're protected while they're making it ready for market and the first thing they look for is a solid IT position."
For the entire article and to sign up to become a subscriber (you should) go to genome-technology.com
"...More academics follow through on patenting because it can be the fastest and most effective way of getting a research breakthrough to the public. Companies that have to commercialize new technology or other types of discovers want some assurance that they're protected while they're making it ready for market and the first thing they look for is a solid IT position."
For the entire article and to sign up to become a subscriber (you should) go to genome-technology.com